Contract with Customer, Liability, Noncurrent in USD of Can-Fite BioPharma Ltd. from Q4 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
Can-Fite BioPharma Ltd. quarterly Contract with Customer, Liability, Noncurrent history and change rate from Q4 2022 to Q2 2025.
  • Can-Fite BioPharma Ltd. Contract with Customer, Liability, Noncurrent for the quarter ending 30 Jun 2025 was $1.38M, a 3.62% decline year-over-year.
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $1.38M -$52K -3.62% 30 Jun 2025 6-K 28 Aug 2025
Q4 2024 $1.58M -$132K -7.71% 31 Dec 2024 6-K 28 Aug 2025
Q2 2024 $1.44M 30 Jun 2024 6-K 29 Aug 2024
Q4 2023 $1.71M -$582K -25.4% 31 Dec 2023 20-F 14 Apr 2025
Q4 2022 $2.3M 31 Dec 2022 20-F 28 Mar 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.